Launch Diagnostics delivered audited revenues of £17.9 million and profit after tax of £0.38 million in the year ended 31 December 2023 and has traded in line with the Board’s expectations ...

Avacta Therapeutics to sell Launch Diagnostics to Duomed Belgium NV for £12.9 million in cash: London Monday, March 10, 2025, 12:00 Hrs [IST] Avacta Therapeutics, a life sciences ...

"We are proud to offer this critical Measles Virus Primer Set during such an important time," said Jerry Boonyaratanakornkit, Scientist at Fort Worth Diagnostics. The Fort Worth Diagnostics Primer ...

Exact Sciences projects 11% total revenue growth in 2025, driven by a 13% increase in screening revenue and the launch of new diagnostics, including Cologuard Plus. With strong operational ...